Metastatic Breast Cancer Treatment

December 16, 2025

Enhertu (Trastuzumab Deruxtecan) Treatment of HER2+ Breast Cancer

Charles H. Weaver, MD
November 17, 2023

Truqap (capivasertib) in Breast Cancer

Charles H. Weaver, MD
February 4, 2023

Trodelvy for HR+/HER2– Metastatic Breast Cancer

Charles H. Weaver, MD
February 3, 2022

Personalized Immunotherapy for Advanced Breast Cancer with TILS

Charles H. Weaver, MD
February 21, 2021

PARP Inhibitors Slow Spread of Breast Cancer Caused by Inherited BRCA Mutations

Charles H. Weaver, MD
December 30, 2020

Ibrance Precision Cancer Medicine for Hormone Receptor Positive Breast Cancer

Charles H. Weaver, MD
December 12, 2020

Kisqali Improves Survival in Women with ER+ Advanced Breast Cancer

Charles H. Weaver, MD
November 13, 2020

Treatment of Stage IV – Metastatic Breast Cancer

Charles H. Weaver, MD
June 5, 2020

Tukysa (tucatinib) – HER2 Inhibitor for Treatment of Breast Cancer

Charles H. Weaver, MD
August 7, 2018

Abraxane™ Highly Effective in Metastatic Breast Cancer

Charles H. Weaver, MD
July 6, 2018

Fatigue Common Among Long-Term Survivors of Breast Cancer

Charles H. Weaver, MD